Array Bridge
 
작성일 : 17-12-20
[Array Bridge] LuceBridge ELISA Kit
For Lucentis Biosimilar Comparision

 

LuceBridge ELISA Kit (for Lucentis Biosimilar Comparision)

 

Complete kit for the systematic 3-D conformational comparability analysis of Lucentis biosimilar molecule to

Ranibizumab (Lucentis trade name).

 

 

   클릭하시면 닫힙니다.이미지 저장을 원하시면 마우스 오른쪽클릭후 '다른이름으로 저장'을 하세요

 

 

Ranibizumab is a humanized IgG1 monoclonal antibody fragment (Fab) created from the same parent

antibody as Bevacizumab (Avastin). It is an anti-angiogenic that has been approved to treat the "wet" type of

age-related macular degeneration (AMD, also ARMD), a common form of age-related vision loss. This kit

will allow for conformational comparison between Lucentis Biosimilars and authentic Ranibizumab.

             

    

        Figure1.Ranibizumab Conformational Arrary ELISA from Variable Region

        A450 클릭하시면 닫힙니다.이미지 저장을 원하시면 마우스 오른쪽클릭후 '다른이름으로 저장'을 하세요

                                              Variable Region (L+H) Antibodies

 

 

              Figure2.Ranibizumab Conformational Arrary ELISA from Constant Region

         A450    클릭하시면 닫힙니다.이미지 저장을 원하시면 마우스 오른쪽클릭후 '다른이름으로 저장'을 하세요

                                              Constant Region (L+H) Antibodies

 

 

Supplied Components

Coated Clear 96 Well Plates

5 x Dilution Buffer

10 x PBS-T

Reporting antibody

Streptavidin-HRP Conjugate

TMB Substrate

Stop Solution

Plate Sealer

 

 

Product information  (PDF)

 

 

Ordering information 

Catalog No.

Target

Size

AB000214

 LuceBridge ELISA (for Lucentis Biosimilar Comparision)

1 kit & 5 kits

 

 

▣ 관련 페이지 ; Array Bridge  (바이오시밀러/Biosimilar 구조 평가 ELISA kits, etc.)